Influence of the Immune Checkpoint Inhibitors on the Hemostatic Potential of Blood Plasma
Article in Transfusion Medicine and Hemotherapy (August 2024)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
A case study of a patient with platelet transfusion refractoriness (PTR) combined with human leucocyte antigen (HLA) antibody positivity during hepatic arterial infusion chemotherapy in conjunction with the ‘atezolizumab plus bevacizumab’ regimen
Article in Nursing in Critical Care (July 2024)
Successful Treatment of Steroid-Refractory Immune Thrombocytopenia in a Patient Developing Multiple Myeloma While on Immune Checkpoint Inhibitor Therapy for Lung Cancer: A Case Report
Article in Journal of Blood Medicine (June 2024)